7-Isopropyl-5-methylbicyclo[2.2.2]oct-5-ene-2-carbaldehyde
| Common Name: |
7-Isopropyl-5-methylbicyclo[2.2.2]oct-5-ene-2-carbaldehyde |
| IUPAC Name: |
5-methyl-7-propan-2-ylbicyclo[2.2.2]oct-5-ene-2-carbaldehyde |
| Molecular Formula: |
C10H16O2 |
| SMILES: |
CC1=CC2C(CC1CC2C(C)C)C=O |
| Inchi: |
1S/C13H20O/c1-8(2)12-6-10-5-11(7-14)13(12)4-9(10)3/h4,7-8,10-13H,5-6H2,1-3H3 |
| Inchi Key: |
LKERFQHZNFIXLI-UHFFFAOYSA-N |
| Cas No: |
93904-56-4 |
| Name |
Value |
| Lipinski Violations |
0 |
| Ghose Violations |
0 |
| Veber Violations |
0 |
| Egan Violations |
0 |
| Muegge Violations |
1 |
| Name |
Value |
| Molecular Weight (g/mol) |
168.23 |
| Mass (g/mol) |
192.151 |
| Molar Refractivity |
48.88 |
| Net Charge |
|
| HBD |
|
| HBA |
2 |
| Rt Bonds |
6 |
| Rings |
3 |
| TPSA |
26.30 |
| Hetero Atoms |
1 |
| Heavy Atoms |
12 |
| Aromatic Heavy Atoms |
0 |
| Melting Point (°C) |
|
| Boiling Point (°C@760.00mm Hg) |
269.00 to 270.00 |
| Vapor Pressure (mmHg@25.00 °C) |
0.007 |
| Vapor Density (Air =1) |
|
| Fraction Csp3 |
0.70 |
| LogP |
3.06 |
| iLOGP |
2.61 |
| XLOGP3 |
2.34 |
| WLOGP |
2.23 |
| MLOGP |
2.08 |
| ESOL Log S |
-1.96 |
| ESOL Solubility (mg/ml) |
1.84 |
| ESOL Solubility (mol/l) |
0.011 |
| ESOL Class: esol_class |
Very soluble |
| Ali Log S |
-2.53 |
| Ali Solubility (mg/ml) |
0.5 |
| Ali Solubility (mol/l) |
0 |
| Ali Class |
Soluble |
| Silicos-IT LogSw |
-1.85 |
| Silicos-IT Solubility (mg/ml) |
2.36 |
| Silicos-IT Solubility (mol/l) |
0.01 |
| Silicos-IT Class |
Soluble |
| Name |
Value |
| GI Absorption |
High |
| BBB Permeable |
1 |
| PgP Substrate |
0 |
| Log Kp (cm/s) |
-5.66 |
| Bioavailability Score |
0.55 |
| Caco2 |
1 |
| Human Intestinal Absorption |
1 |
| Plasm Protein Binding |
0.768 |
| CYP1A2 Inhibitor |
0 |
| CYP2C19 Inhibitor |
0 |
| CYP2C9 Inhibitor |
0 |
| CYP2D6 inhibitor |
0 |
| CYP3A4 inhibitor |
0 |
| Ames mutagenesis |
0 |
| Acute Oral Toxicity |
1.902 |
| Carcinogenicity (Binary) |
0 |
| Carcinogenicity (Trinary) |
Non-required |
| Eye Irritation |
1 |
| Hepatotoxicity |
0 |
| Androgen Receptor Binding |
0 |
| Aromatase Binding |
0 |
| Estrogen Receptor Binding |
0 |
| Glucocorticoid Receptor Binding |
0 |
| Thyroid Receptor Binding |
0 |
| BRCP inhibitor |
0 |
| BSEP inhibitor |
0 |
| OATP1B1 inhibitor |
1 |
| OATP1B3 inhibitor |
1 |
| OATP2B1 inhibitor |
0 |
| OCT1 inhibitor |
0 |
| OCT2 inhibitor |
0 |
